Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects
- PMID: 2384545
- DOI: 10.1038/jcbfm.1990.127
Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects
Abstract
A graphical method of analysis applicable to ligands that bind reversibly to receptors or enzymes requiring the simultaneous measurement of plasma and tissue radioactivities for multiple times after the injection of a radiolabeled tracer is presented. It is shown that there is a time t after which a plot of integral of t0ROI(t')dt'/ROI(t) versus integral of t0Cp(t')dt'/ROI(t) (where ROI and Cp are functions of time describing the variation of tissue radioactivity and plasma radioactivity, respectively) is linear with a slope that corresponds to the steady-state space of the ligand plus the plasma volume,.Vp. For a two-compartment model, the slope is given by lambda + Vp, where lambda is the partition coefficient and the intercept is -1/[kappa 2(1 + Vp/lambda)]. For a three-compartment model, the slope is lambda(1 + Bmax/Kd) + Vp and the intercept is -[1 + Bmax/Kd)/k2 + [koff(1 + Kd/Bmax)]-1) [1 + Vp/lambda(1 + Bmax/Kd)]-1 (where Bmax represents the concentration of ligand binding sites and Kd the equilibrium dissociation constant of the ligand-binding site complex, koff (k4) the ligand-binding site dissociation constant, and k2 is the transfer constant from tissue to plasma). This graphical method provides the ratio Bmax/Kd from the slope for comparison with in vitro measures of the same parameter. It also provides an easy, rapid method for comparison of the reproducibility of repeated measures in a single subject, for longitudinal or drug intervention protocols, or for comparing experimental results between subjects. Although the linearity of this plot holds when ROI/Cp is constant, it can be shown that, for many systems, linearity is effectively reached some time before this. This analysis has been applied to data from [N-methyl-11C]-(-)-cocaine ([11C]cocaine) studies in normal human volunteers and the results are compared to the standard nonlinear least-squares analysis. The calculated value of Bmax/Kd for the high-affinity binding site for cocaine is 0.62 +/- 0.20, in agreement with literature values.
Similar articles
-
Concentration and occupancy of dopamine transporters in cocaine abusers with [11C]cocaine and PET.Synapse. 1997 Dec;27(4):347-56. doi: 10.1002/(SICI)1098-2396(199712)27:4<347::AID-SYN8>3.0.CO;2-C. Synapse. 1997. PMID: 9372557
-
Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomography.J Cereb Blood Flow Metab. 1991 Mar;11(2):204-19. doi: 10.1038/jcbfm.1991.52. J Cereb Blood Flow Metab. 1991. PMID: 1847703
-
Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil.J Cereb Blood Flow Metab. 1993 Jul;13(4):656-67. doi: 10.1038/jcbfm.1993.84. J Cereb Blood Flow Metab. 1993. PMID: 8391018
-
In vivo potency revisited - Keep the target in sight.Pharmacol Ther. 2018 Apr;184:177-188. doi: 10.1016/j.pharmthera.2017.10.011. Epub 2017 Oct 10. Pharmacol Ther. 2018. PMID: 29024741 Review.
-
Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments.Crit Rev Neurobiol. 1999;13(2):199-225. doi: 10.1615/critrevneurobiol.v13.i2.40. Crit Rev Neurobiol. 1999. PMID: 10512490 Review.
Cited by
-
[18F]Fluspidine-A PET Tracer for Imaging of σ1 Receptors in the Central Nervous System.Pharmaceuticals (Basel). 2024 Jan 28;17(2):166. doi: 10.3390/ph17020166. Pharmaceuticals (Basel). 2024. PMID: 38399380 Free PMC article. Review.
-
EEG Frequency Correlates with α2-Receptor Density in Parkinson's Disease.Biomolecules. 2024 Feb 10;14(2):209. doi: 10.3390/biom14020209. Biomolecules. 2024. PMID: 38397446 Free PMC article.
-
PET KinetiX-A Software Solution for PET Parametric Imaging at the Whole Field of View Level.J Imaging Inform Med. 2024 Jan 10. doi: 10.1007/s10278-023-00965-z. Online ahead of print. J Imaging Inform Med. 2024. PMID: 38343229
-
Brain 11β-Hydroxysteroid Dehydrogenase Type 1 Occupancy by Xanamem™ Assessed by PET in Alzheimer's Disease and Cognitively Normal Individuals.J Alzheimers Dis. 2024;97(3):1463-1475. doi: 10.3233/JAD-220542. J Alzheimers Dis. 2024. PMID: 38250767 Free PMC article.
-
Brain PET imaging using 11C-flumazenil and 11C-buprenorphine does not support the hypothesis of a mutual interaction between buprenorphine and benzodiazepines at the neuroreceptor level.J Cereb Blood Flow Metab. 2024 Mar;44(3):449-458. doi: 10.1177/0271678X231221040. Epub 2023 Dec 14. J Cereb Blood Flow Metab. 2024. PMID: 38097513
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
